High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy

PURPOSE: Although programmed death-ligand 1 (PD-L1) expression is widely accepted as a predictive and prognostic biomarker in immunotherapy, its implications in lung cancer patients with driving mutations are still unclear. The objective of this study is to determine the association between PD-L1 ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Byung Woo, Chang, Boksoon, Lee, Seung Hyeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445533/
https://www.ncbi.nlm.nih.gov/pubmed/32903896
http://dx.doi.org/10.2147/OTT.S271011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445533/
https://www.ncbi.nlm.nih.gov/pubmed/32903896
http://dx.doi.org/10.2147/OTT.S271011

Ejemplares similares